Treating Progressive Multifocal Leukoencephalopathy With Interleukin 7 and Vaccination With JC Virus Capsid Protein VP1-Reference-Cited by-同舟云学术

Treating Progressive Multifocal Leukoencephalopathy With Interleukin 7 and Vaccination With JC Virus Capsid Protein VP1

Published:2014-09-11 Issue:11 Volume:59 Page:1588-1592
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Sospedra Mireia,Schippling Sven,Yousef Sara,Jelcic Ilijas,Bofill-Mas Silvia,Planas Raquel,Stellmann Jan-Patrick,Demina Viktoria,Cinque Paola,Garcea Robert,Croughs Therese,Girones Rosina,Martin Roland

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/59/11/1588/17854459/ciu682.pdf

Reference12 articles.

1. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis;Tan;Lancet Neurol,2010

2. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy;Cinque;J Neurovirol,2001

3. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome;Aly;Brain,2011

4. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome;Gheuens;J Virol,2011

5. Anti-JC virus antibodies: implications for PML risk stratification;Gorelik;Ann Neurol,2010

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the Power of IL-7 to Boost T Cell Immunity in Experimental and Clinical Immunotherapies;Immune Network;2024

2. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era;Frontiers in Cellular and Infection Microbiology;2023-11-08

3. Upregulation of the NKG2D ligand ULBP2 by JC polyomavirus infection promotes immune recognition by natural killer cells;2023-06-02

4. Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report;Therapeutic Advances in Hematology;2023-01

5. IL-7: Comprehensive review;Cytokine;2022-12